Joyce M. Lehner
10Patents
3h-index
21Co-inventors
56Inventor score
Filing activity: Oct 4, 1995 → Jan 12, 2012
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5827734A | Materials and methods for determining ob protein in a biological sample | Human Necessities | 18 | Expired |
| US7393684B2 | Immunoconjugates of anti-IL-20 antibodies and hybridoma cell lines expressing anti-IL-20 antibodies | Chemistry; Metallurgy | 14 | Expired |
| US7537761B2 | Anti-IL-22RA antibodies and binding partners and methods of using in inflammation | Emerging Cross-Sectional Technologies | 9 | Active |
| US8163286B2 | Anti-IL-22RA antibodies and binding partners and methods of using in inflammation | Chemistry; Metallurgy | 1 | Active |
| US8124088B2 | Methods of treatment using anti-IL-22RA antibodies | Emerging Cross-Sectional Technologies | 1 | Active |
| US8907068B2 | Anti-IL-20 antibodies and binding partners and methods of using in inflammation | Chemistry; Metallurgy | 0 | Active |
| US7871616B2 | Anti-IL-22RA antibodies and binding partners and methods of using in inflammation | Emerging Cross-Sectional Technologies | 0 | Active |
| US6630571B1 | Mammalian growth factor-7 | Chemistry; Metallurgy | 0 | Expired |
| US8536309B2 | Methods of producing anti-IL-22RA antibodies | Emerging Cross-Sectional Technologies | 0 | Active |
| US6271343A | Mammalian cytokine-like receptor 5 | Chemistry; Metallurgy | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.